Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02193347
Title IDH1 Peptide Vaccine for Recurrent Grade II Glioma (RESIST)
Acronym RESIST
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Gary Archer Ph.D.
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Duke University Medical Center Durham North Carolina 27710 United States Details
*Shaded cells indicate that there was no data available from for the field